You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Homatropine Methylbromide And Hydrocodone Bitartrate patents expire, and when can generic versions of Homatropine Methylbromide And Hydrocodone Bitartrate launch?

Homatropine Methylbromide And Hydrocodone Bitartrate is a drug marketed by Actavis Elizabeth, Avanthi Inc, and Novel Labs Inc. and is included in three NDAs.

The generic ingredient in HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Homatropine Methylbromide And Hydrocodone Bitartrate

A generic version of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE was approved as homatropine methylbromide; hydrocodone bitartrate by AVANTHI INC on August 7th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE?
  • What are the global sales for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE?
  • What is Average Wholesale Price for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE?
Summary for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
Drug patent expirations by year for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
Pharmacology for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists

US Patents and Regulatory Information for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 040295-001 Dec 1, 2000 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Avanthi Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 207176-001 Aug 7, 2017 AA RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novel Labs Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 091528-001 Apr 20, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.